+147.0%
MRNA vs VALE
-19.8%
+166.7%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | VALE | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -3.5% | +1.3% | 0.0% |
| 7D | -12.7% | -15.4% | +2.7% | -3.2% |
| 30D | -20.7% | -25.3% | +4.6% | -4.8% |
| 3M | +46.3% | -33.3% | +79.6% | +86.7% |
| 6M | +305.2% | -40.3% | +345.5% | +442.3% |
| YTD | +561.2% | -25.1% | +586.3% | +682.2% |
| 1Y | +772.1% | -13.8% | +785.9% | +856.4% |
| 3Y | +147.0% | -20.5% | +167.4% | +185.7% |
| All | +147.0% | -19.8% | +166.7% | +185.7% |
Cumulative growth
Daily Returns
Daily percentage return beside VALE.
Daily Out/Under-Performance
Portfolio return minus VALE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VALE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded VALE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling